# ClinicalTrials.gov record NCT00191893

> PeptideScanner retained ClinicalTrials.gov record NCT00191893 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct00191893-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2007-01-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00191893-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00191893-teriparatide-v1.json
- Content SHA-256: `191f027d24bd27e06f3c39027783d29980668dd0c09a9ba6fa7cfc2214a243af`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00191893 ([`ctg-observation-nct00191893-2007-01-26-2c0809a5796b`](#source-ctg-observation-nct00191893-2007-01-26-2c0809a5796b))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00191893 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00191893-2007-01-26-2c0809a5796b`](#source-ctg-observation-nct00191893-2007-01-26-2c0809a5796b))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00191893 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00191893-2007-01-26-2c0809a5796b`](#source-ctg-observation-nct00191893-2007-01-26-2c0809a5796b))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00191893-2007-01-26-2c0809a5796b`](#source-ctg-observation-nct00191893-2007-01-26-2c0809a5796b))

## Sources

<a id="source-ctg-observation-nct00191893-2007-01-26-2c0809a5796b"></a>
- **ClinicalTrials.gov record NCT00191893 · retained source version 2007-01-26:2c0809a5796b95b003e4e7f3dad0db6cfdb5c3e7ec0e1370f9012f3593f089aa** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00191893) (`ctg-observation-nct00191893-2007-01-26-2c0809a5796b`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00191893." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00191893-teriparatide-v1.json SHA-256: 191f027d24bd27e06f3c39027783d29980668dd0c09a9ba6fa7cfc2214a243af.